YHLO_YHLO News

YHLO initiates win-win cooperation with Beckman Coulter

Time Posted : 2021-08-18

Spotlight of IVD industry, YHLO was interviewed by CCTV

Time Posted : 2021-06-24

Congratulations! YHLO relocated, a new start to excellence

Time Posted : 2021-06-24

YHLO Nanshan branch relocated to Wisdom Plaza, a new start to strive for excellence

YHLO Rapid Antigen Test Kits Approved by BfArM

Time Posted : 2021-04-20

iFlash-2019-nCoV CLIA kits NMPA Certified

Time Posted : 2020-09-30

First Fruit of the New Partnership: YHLO's Adventure in Tokyo

Time Posted : 2020-09-18

YHLO recently achieved new achievements with our scientific partner in Covid-19 study.

Joint Donation to Japanese Medical Institutions

Time Posted : 2020-05-21

A total of 400,000 disposable medical masks and 500 protective suits are donated to Japanese medical institutions.

Good News! YHLO Medical Mask is Ready for Exportation

Time Posted : 2020-05-20

With strong R&D force, YHLO mask became available in a short time and quickly got CE marked in March and NMPA (National Medical Products Administration) approved in April. As of now, YHLO is all ready for mask exportation!

...

Home

About YHLO

Products

Services

News

Company Profile Milestone Corporate Values

About YHLO

YHLO (EST. 2008) is an innovative and steadfastly growing company of immunoassay solutions headquartered in Shenzhen, China, specialized in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents by a team of experienced scientists and engineers. In May of 2021, YHLO has successfully launched IPO and listed on Shanghai Stock Exchange (Stock code: 688575).

More +

Clinical Solution CLIA ELISA LIA POCT ESR COVID-19

Products

Based on the technology platforms of CLIA, ELISA, LIA and immunofluorescence, YHLO is specialized in diagnosis of autoimmunity, reproductive health, diabetes, infectious diseases etc.

More +